QQ客服 官方微博 反馈留言

	Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells
	Zhang, Jinming[1,2]; Wang, Lu[1]; Chan, Hon Fai[3]; Xie, Wei[4]; Chen, Sheng[4]; He, Chengwei[1]; Wang, Yitao[1]; Chen, Meiwan[1]
	2017
卷号	7
URL标识	查看原文
WOS记录号	WOS:000400554700001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4294233
专题	成都中医药大学
作者单位	1.[1]Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Sch Pharm, Chengdu 611137, Peoples R China 3.[3]Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA 4.[4]Shenzhen Tradit Chinese Med Hosp, Dept Resp Med, Shenzhen 518033, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Jinming[1,2],Wang, Lu[1],Chan, Hon Fai[3],et al. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells[J],2017,7.
APA	Zhang, Jinming[1,2].,Wang, Lu[1].,Chan, Hon Fai[3].,Xie, Wei[4].,Chen, Sheng[4].,...&Chen, Meiwan[1].(2017).Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.,7.
MLA	Zhang, Jinming[1,2],et al."Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells".7(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。